Importantly, the fact that 'size' olfactory information modulates the hand at the level of individual digits (and not only the thumb-index distance as previously reported) leads to two important considerations in terms of sensorimotor transformation.
In this paper, we present major extensions to the previously reported framework to enable rigorous consideration of strain hardening and the concomitant evolution of the crystallographic texture with imposed plastic strain.
However, this result is less surprising when the broad size distribution of particles of chewed almonds is taken into consideration, as previously reported (Grundy et al., 2015).
The material submitted has been approved by all authors, has not been previously reported, and is not under consideration for publication elsewhere.
A serious unanticipated ADE or a percentage of subjects experiencing a specific serious ADE higher than previously reported were defined as criteria for consideration of modification or termination of the study.
In consideration of the previously reported literatures and our report, we considered that exons 1 and 5 probably were hotspot regions of the UGT1A1 gene in Asian populations especially in Japanese and Chinese and p.G71R and p.Y486D were two most common variants leading to UGT1A1 genetically-associated unconjugated hyperbilirubinemia.
We did not detect the previously reported QTL Chcmq2, possibly because of power considerations, or Chcmq8, which was female-specific.
This may have important clinical considerations, as we have previously reported that loss of p21 expression is seen in up to 40% of human breast cancers [ 36].
These considerations are supported by previously reported results from cohort 2, in which xeno-estrogenic activity in serum from the women was measured as a marker for occupational pesticide exposure [ 39].
In line with these considerations, it has been previously reported that one of the leading pathways involved in the regulation of embryonic stem cell differentiation and resistance of MDB CSCs to therapy is PI3K/AKT signalling [ 46, 47].
